We are a Deep Tech 3D Bioprinting Company focussed on the development of products and services for R&D and clinical applications. Our multi-disciplinary team that is working to change the paradigm of Indian and Global 3D Bioprinting research and development.
We developed our first 3D Bioprinter within the first 7 months, since our inception in May 2016. To create an impact in the domain of 3D Bioprinting, We, at NBIL, developed Trivima, India’s first customisable 3D Bioprinter. The printer has been developed to cater to the diverse requirements of researchers working in the domain of 3D Bioprinting in India.
With a long term vision to one day bridge the gap between organ demand and availability via 3D Bioengineered organs, our team has taken its first step in that direction. We are currently in the final stages of development of 3D Bioprinted Human Skin (Innoskin®). Although the initial application for the Bioprinted Skin would be in cosmetic, pharmaceutical and chemical testing applications, the long term goal of us at NBIL is to translate its 3D Bioprinted Skin into a clinical use case.
No single entity can achieve what we want to achieve – This is the belief within the company. We have developed a platform – “Jivan” (made up of the team, tech, processes and patents) – that allows researchers and companies alike to use in order to create a leapfrog jump in the state of research in 3D Bioprinting.